The first Vyant Bio trade was made in Q2 2021.
Since then Ken Griffin bought shares three more times and sold shares on three occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Vyant Bio anymore.
Avg closing price
Price range
Sold -11.2 Thousand shares
Q1 2023
Avg closing price
$0.80
Price range
$0.58
-
$1.21
Increased shares by 160.4% (+6.91 Thousand shares)
Q4 2022